CRYSTALLINE SOLVATED FORMS OF N-(4-(1-(2,6-DIFLUOROBENZYL)-5- ((DIMETHYLAMINO)METHYL)-3-(6-METHOXY-3-PYRIDAZINYL)-2,4-DIOXO-1,2,3,4- TETRAHYDROTHIENO[2,3-D]PYRIMIDIN-6-YL)PHENYL)-N'-METHOXYUREA

CRYSTALLINE FORMS OF ENTRECTINIB

RESMETIROM CRYSTAL, PREPARATION METHOD FOR SAME, AND USES THEREOF

Crystalline forms of phthalazinone compound

SALTS AND SOLID STATE FORMS OF PLINABULIN

SOLID STATE FORMS OF PEMAFIBRATE

CRYSTAL FORM OF BENZIMIDAZOLE-2-ONE COMPOUND, SOLVATE THEREOF, CRYSTAL FORM OF SOLVATE THEREOF, AND PREPARATION METHOD THEREOF

Crystalline polymorphs of Rivoceranib and Rivoceranib mesylate

Salt forms of URAT-1 inhibitors

CRYSTALLINE POLYMORPHIC FORM OF PSILOCIN

(C)CRYSTAL COMPOSITION (CC) COMPRISING 4,4'-DICHLORODIPHENYLSULFONE CRYSTALS (C)

Polymorphic compounds and uses thereof

METHOD FOR MANUFACTURING REVAUDIOSIDE-D-CONTAINING CRYSTALLIZED PRODUCT, AND REVAUDIOSIDE-D-CONTAINING CRYSTALLIZED PRODUCT

METHOD FOR PREPARING HETEROCYCLIC DERIVATIVE COMPOUND, COMPOSITION CONTAINING SAME COMPOUND, AND HYDRATE OF SAME COMPOUND

NOVEL SALTS AND CRYSTALS

Solid forms of a modulator of hemoglobin

5-(Thiophen-2-YL)-1 H-Tetrazole Derivative as BCKDK Inhibitors Useful for Treating Various Diseases

Pyrazolyl derivatives useful as anti-cancer agents

Crystalline forms of (S)-1-(1-acryloylpyrrolidin-3-yl)-3-((3,5-dimethoxyphenyl)ethynyl)-5-(methylamino)-1H-pyrazole-4-carboxamide

Cocrystals, pharmaceutical compositions thereof, and methods of treatment involving same

Salt and solid state forms of escatalopram

Crystalline forms of psilacetin

CRYSTALLINE FORM OF CAPSID PROTEIN ASSEMBLY INHIBITOR CONTAINING N HETERO FIVE-MEMBERED RING, AND APPLICATION THEREOF

Polymorphic forms of N-(4-((4-(3-phenylureido)phenyl)sulfonyl)phenyl)benzolsulfonamide

Compositions and methods for solidified fermented animal feed

Polypeptide integrin antagonists

Polymorphic forms of kinase inhibitor compound, pharmaceutical composition containing same, preparation method therefor and use thereof

SOLID STATE FORMS OF ROLUPERIDONE AND SALTS THEREOF

Solid forms of 3-(5-Fluorobenzofuran-3-yl)-4-(5-methyl-5H-[1,3]dioxolo[4,5-f]indol-7-yl)pyrrole-2,5-dione

Crystal forms of (s)-4-(8-amino-3-(1-(but-2-ynoyl)pyrrolidin-2-yl)imidazo[1,5-a]pyrazin-1-yl)-n-(pyridin-2-yl)benzamide

Crystalline forms of diazabicyclooctane derivative and production process thereof

LSD SALT CRYSTAL FORMS

Crystals of tetrahydronaphthyl urea derivative

Process for the preparation of a PDE4 inhibitor

SALTS OF OMECAMTIV MECARBIL AND SOLID FORMS THEREOF

PROCESS FOR SYNTHESIZING APREMILAST

CRYSTALLINE FORMS OF BEMPEDOIC ACID

Menaquinol compositions and methods of treatment

Method for preparing heterocyclic derivative compound, composition containing same compound, and hydrate of same compound

CHEMICAL COMPOUNDS

Crystalline form of (S)-7-(1-acryloylpiperidin-4-yl)-2-(4-phenoxyphenyl)-4,5,6,7-tetra-hydropyrazolo[1,5-a]pyrimidine-3-carboxamide, preparation, and uses thereof

Crystalline form of (S)-7-(1-acryloylpiperidin-4-yl)-2-(4-phenoxyphenyl)-4,5,6,7-tetra- hydropyrazolo[1,5-a]pyrimidine-3-carboxamide, preparation, and uses thereof

Solid polymorphs of a FLNA-binding compound and its hydrochloride salts

1,2,4-OXADIAZOLE DERIVATIVES AS LIVER X RECEPTOR AGONISTS

VMAT2 INHIBITOR AND PREPARATION METHOD THEREFOR AND APPLICATION THEREOF

CRYSTALLINE FORM OF CXCR2 ANTAGONIST AND APPLICATION THEREOF

SALTS OF OMECAMTIV MECARBIL AND SOLID FORMS THEREOF

Fumarate salt of (R)-3-(1-(2,3-dichloro-4-(pyrazin-2-yl)phenyl)-2,2,2-trifluoroethyl)-1-methyl-1-(1-methylpiperidin-4-yl)urea, methods of preparation, and uses thereof

A SALT AND CRYSTAL FORM OF A FAK INHIBITOR

RREPARATION METHOD OF 3-MERCAPTOPROPIONIC ACID

Vidofludimus for use in the treatment or prevention of viral diseases

(17-)-3-Oxoandrost-4-EN-17-YL Dodecanoate Compositions and Methods of Preparation and Use

D-PSICOSE CRYSTAL AND PREPARATION METHOD THEREFOR

NEW CRYSTAL FORM OF AN ORGANIC FLUORESCENT COMPOUND

CRYSTALLINE FORMS OF A JAK2 INHIBITOR

NON-HYGROSCOPIC CRYSTALLINE SALTS OF A PYRAZOLE COMPOUND, AND PHARMACEUTICAL COMPOSITIONS AND USE THEREOF

CRYSTAL FORM OF FIVE-MEMBERED N HETEROCYCLIC COMPOUND, AND APPLICATION THEREOF

CAANABIGEROL PROLINE COCRYSTALS

Hydrated crystalline form of 2-acrylamido-2-methylpropane sulfonic acid

Process for the preparation of cortexolone 17α-propionate and new hydrated crystalline form thereof

CRYSTAL FORM OF SGLT INHIBITOR AND APPLICATION THEREOF

PROCESS FOR PREPARATION OF 2-HYDROXY-6-((2-(1-ISOPROPYL-1H-PYRAZOL-5-YL)PYRIDIN-3-YL)METHOXY)BENZALDEHYDE

STABLE CRYSTALLINE APALUTAMIDE IN PURE FORM, AND PROCESS FOR THE PREPARATION THEREOF

METHODS AND COMPOSITIONS FOR GAMMA-GLUTAMYL CYCLE MODULATION

Elagolix Sodium Compositions and Processes

Co-crystal of Compound I Dihydrochloride and Preparation Method and Use Thereof

METHOD FOR PURIFYING AN ORGANIC COMPOUND

METHODS FOR RECOVERING ORGANIC ACIDS OR SALTS OR LACTONES THEREOF FROM AQUEOUS SOLUTIONS USING WATER SOLVENT CRYSTALLIZATION AND COMPOSITIONS THEREOF

Method for producing functional crystalline sweetener

CONTINUOUS PREPARATION METHOD FOR PENEM INTERMEDIATE MAP

METFORMIN COMPLEXES WITH TRANSITION METALS AND P GROUP ELEMENTS

SOLID STATE FORMS OF RISDIPLAM AND PROCESS FOR PREPARATION THEREOF

IMPROVED PROCESS FOR THE PREPARATON OF PURE (1'R,6R,6aR,7R,13S,14S,16R)-5-(ACETYLOXY)-3',4',6,6a,7,13,14,16-OCTAHYDRO-6',8,14-TRIHYDROXY-7',9-DIMETHOXY-4,10,23-TRIMETHYLSPIRO[6,16-(EPITHIOPROPANOXYMETH ANO)-7,13-IMINO-12H-1,3-DIOXOLO[7,8]ISOQUINO[3,2-b][3]BENZAZOCINE-20,1'(2'H)-ISOQUINOLIN]-19-ONE POLYMORPH THERE OF

POLYMORPH OF CDK9 INHIBITOR AND PREPARATION METHOD FOR POLYMORPH AND USE THEREOF

POLYMORPHS OF (R)-N-(5-(5-ETHYL-1,2,4-OXADIAZOL-3-YL)-2,3-DIHYDRO-1H-INDEN-1-YL)-1-METHYL-1H-PYRAZOLE-4-CARBOXAMIDE

Crystalline form and B crystalline form of pyrazine-2(1H)-ketone compound and preparation method thereof

POLYMORPHS OF 1-(2-((((TRANS)-3-FLUORO-1-(3-FLUOROPYRIDIN-2-YL)CYCLOBUTYL)METHYL)AMINO)PYRIMIDIN-5-YL)-1H-PYRROLE-3-CARBOXAMIDE

Sulfasalazine salts, production processes and uses

PROCESS AND POLYMORPHIC FORMS OF BICTEGRAVIR AND ITS PHARMACEUTICALLY ACCEPTABLE SALTS OR CO-CRYSTALS THEREOF

Processes for the preparation of (3S,4R)-3-ethyl-4-(3H-imidazo[1,2-a]-pyrazin-8-yl)-N-(2,2,2-trifluoroethyl)pyrrolidine-1-carboxamide and solid state forms thereof

Crystalline solid forms of a bet inhibitor

CRYSTALLINE FORM OF A DIHYDROCHLORIDE SALT OF A JAK INHIBITOR COMPOUND

SALT AND CRYSTAL FORM OF MTORC1/2 DUAL KINASE ACTIVITY INHIBITOR AND PREPARATION METHOD THEREFOR

Crystalline form of 1,4-bis[1,2-benzisoselenazol-3(2H)-one]-butane, method for preparing same and use thereof

Anhydrous Crystal of Monosodium N-(2-Ethylsulfonylamino-5-Trifluoromethyl-3-Pyridyl)Cyclohexane Carboxamide

Crystalline freebase forms of a biphenyl compound

Process for the preparation of D,L-methionine

CRYSTALLINE FORMS OF HYDROXYNORKETAMINE

Two-dimensional coordination polymers

Processes for the preparation of (3S,4R)-3-ethyl-4-(3H-imidazo[1,2-a]pyrrolo[2,3-e]-pyrazin-8-yl)-n-(2,2,2-trifluoroethyl)pyrrolidine-1 carboxamide and solid state forms thereof

Processes for the preparation of (3S,4R)-3-ethyl-4-(3H-imidazo[1,2-α]pyrrolo[2,3-e]-pyrazin-8-yl)-N-(2,2,2-trifluoroethyl)pyrrolidine-1-carboxamide and solid state forms thereof

SOLID FORMS OF {6-[(2-AMINO-3-CHLOROPYRIDIN-4-YL)SULFANYL]-3-[(3S,4S)-4-AMINO-3-METHYL-2-OXA-8-AZASPIRO[4.5]DECAN-8-YL]-5-METHYLPYRAZIN-2-YL}METHANOL, A SHP2 INHIBITOR

POLYMORPH OF VENETOCLAX AND METHOD FOR PREPARING THE POLYMORPH

CRYSTALLINE FORMS OF [3-(4- {2-BUTYL-1-[4-(4-CHLORO-PHENOXY)-PHENYL]-1H-IMIDAZOL-4-YL} -PHENOXY)-PROPYL]-DIETHYL-AMINE

PROCESS FOR THE PREPARATION OF KEY INTERMEDIATES FOR THE SYNTHESIS OF ELTROMBOPAG OR SALT THEREOF

CRYSTALLINE FORM OF SOFPIRONIUM BROMIDE AND PREPARATION METHOD THEREOF

Formulations of 4-Methyl-5-(Pyrazin-2-yl)-3H-1,2-Dithiole-3-Thione, Taste-Modified Formulations, and Methods of Making and Using Same

SYNTHESIS AND PURIFICATION OF CANNABIGEROL AND ITS APPLICATION

Cystic Fibrosis Transmembrane Conductance Regulator Stabilizing Agents

Hemi-citrate salts of GABA-A positive allosteric modulator and crystalline form thereof

PROCESS FOR PREPARING AN E-SELECTIN INHIBITOR INTERMEDIATE

CRYSTAL OF CARCINOGENIC FUSED KINASE INHIBITOR AND APPLICATIONS THEREOF

CRYSTALLINE LORLATINIB : FUMARIC ACID AND SOLID STATE FORM THEREOF

CRYSTALLINE FORM B OF TETRAHYDROTHIENOPYRIDINE COMPOUND, PREPARATION METHOD, COMPOSITION AND APPLICATION THEREOF

Crystalline salt of a multi-tyrosine kinase inhibitor, method of preparation, and use thereof

STABLE POLYMORPHIC FORM OF 6-FLUORO-9-METHYL-9H-B-CARBOLINE AND USES THEREOF

Crystal forms C and E of pyrazin-2(1H)-one compound and preparation method therefor

CRYSTALLINE FORMS OF A CD73 INHIBITOR

SOLID FORMS COMPRISING (S)-4-(4-(4-(((2-(2,6-DIOXOPIPERIDIN-3-YL)-1-OXOISOINDOLIN-4-YL)OXY)METHYL)BENZYL)PIPERAZIN-1-YL)-3-FLUOROBENZONITRILE AND SALTS THEREOF, AND COMPOSITIONS COMPRISING AND METHODS OF USING THE SAME

POLYMORPHIC FORMS OF (R)-4-(1-((3-(DIFLUOROMETHYL)-1-METHYL-1H-PYRAZOL-4-YL)SULFONYL)-1-FLUOROETHYL)-N-(ISOXAZOL-3-YL)PIPERIDINE-1-CARBOXAMIDE

PROCESS FOR THE PREPARATION OF RIDINILAZOLE AND CRYSTALLINE FORMS THEREOF

Benzisoxazole derivative

MOLECULAR COMPLEXES

METHODS FOR MAKING DIMERIC NAPHTHALIMIDES AND SOLID STATE FORMS OF THE SAME

SALT AND CRYSTAL FORM OF COMPOUND HAVING AGONISTIC ACTIVITY TO S1P5 RECEPTOR

A PROCESS FOR PRODUCING 4,4'-DICHLORODIPHENYL SULFONE

Hydrated crystalline form of 2-acrylamido-2-methylpropane sulfonic acid

PROCESS FOR THE PREPARATION OF A METASTABLE CRYSTAL MODIFICATION OF N-(AMINOIMINOMETHYL)-2-AMINOETHANOIC ACID (IV)

METHOD FOR THE PRODUCTION OF A DICARBOXYLIC ACID

Salts of the Janus Kinase Inhibitor (R)-3-(4-(7h-Pyrrolo[2,3-D]Pyrimidin-4-YL)-1h-Pyrazol-1-Yl)-3- Cyclopentylpropanenitrile

PHARMACEUTICAL COMPOSITIONS CONTAINING SUBSTITUTED POLYCYCLIC PYRIDONE DERIVATIVES AND PRODRUG THEREOF

PROCESSES FOR THE PREPARATION OF (3S,4R)-3-ETHYL-4-(3H-IMIDAZO[1,2-a]PYRROLO[2,3-e]-PYRAZIN-8-YL)-N-(2,2,2-TRIFLUOROETHYL)PYRROLIDINE-1-CARBOXAMIDE AND SOLID STATE FORMS THEREOF

Crystalline form of (S)-7-(1-acryloylpiperidin-4-yl)-2-(4-phenoxyphenyl)-4,5,6,7-tetra- hydropyrazolo[1,5-a]pyrimidine-3-carboxamide, preparation, and uses thereof

CRYSTALLINE FORMS OF PYRIMIDINO DIAZEPINE DERIVATIVE

SALT AND CRYSTAL FORMS OF AN ACTIVIN RECEPTOR-LIKE KINASE INHIBITOR

Lumateperone bis-tosylate salts and crystals and methods for manufacture thereof

CRYSTALLINE FORM OF ATR INHIBITOR AND USE THEREOF

Crystal form D of pyrazine-2(1H)-ketone compound and preparation method therefor

EGFR INHIBITOR FREE BASE OR ACID SALT POLYCRYSTALLINE FORM, PREPARATION METHOD THEREFOR, AND APPLICATION

PROCESS FOR THE PREPARATION OF APALUTAMIDE

Crystal modifications of odevixibat

SALT

Methods of making bempedoic acid and compositions of the same

METHOD OF THE ISOLATING CHLOROSESAMONE OR CHLOROSESAMONE-CONTAINING FRACTION FROM ROOTS OF GENUS SESAMUM, AND APPLICATION OF THE FRACTION THEREOF

Enzymatic process for obtaining 17 alpha-monoesters of cortexolone and/or its 9,11-dehydroderivatives

PROCESSES OF MAKING AND CRYSTALLINE FORMS OF A MDM2 INHIBITOR

SALT AND CRYSTAL FORM OF STEROID DERIVATIVE REGULATOR

Crystalline forms

MOLECULAR COMPLEXES

CRYSTALLINE FORM OF (S)-7-(1-ACRYLOYLPIPERIDIN-4-YL)-2-(4-PHENOXYPHENYL)-4,5,6,7-TETRA-HYDROPYRAZOLO[1,5-a]PYRIMIDINE-3-CARBOXAMIDE, PREPARATION, AND USES THEREOF

NOVEL INHIBITORS

POLYMORPHS OF (R)-N-(5-(5-ISOPROPYL-1,2,4-OXADIAZOL-3-YL)-2,3-DIHYDRO-1H-INDEN-1-YL)-2-METHYL-2H-TETRAZOLE-5-CARBOXAMIDE

SURFACTANT SYSTEMS FOR CRYSTALLIZATION OF ORGANIC COMPOUNDS

Formulations of an AXL/MER inhibitor

Process for the preparation of the polymorph F of sodium neridronate

Processes for the preparation of (3S,4R)-3-ethyl-4-(3H-imidazo[1,2-a]pyrrolo[2,3-e]-pyrazin-8-yl)-n-(2,2,2-trifluoroethyl)pyrrolidine-1-carboxamide and solid state forms thereof

SOLID FORMS OF TERT-BUTYL (S)-2((2S,3R)-1-AMINO-3-HYDROXY-1-OXOBU TAN-2-YL)-1-OXO-2, 5-DIAZASPIRO [3.4] OCTAN E-5-CARBOXYLATE AND METHODS OF PREPARING THEM

DOSAGE FORM COMPOSITIONS COMPRISING AN INHIBITOR OF BRUTON'S TYROSINE KINASE

Hydrates of polymorphs of 6-(1H-indazol-6-yl)-N-(4-morpholinophenyl)-2,3-dihydroimidazo[1,2-a]pyrazin-8-amine bis-mesylate as Syk inhibitors

CRYSTALLINE FORMS OF AN ORALLY AVAILABLE, SELECTIVE KIT AND PDGFR KINASE INHIBITOR

CRYSTALLINE FORM OF VALBENAZINE DITOSYLATE, PROCESSES FOR PREPARATION THEREOF AND USE THEREOF

Crystalline forms of -(3-(2-(2-hydroxyethoxy)-6-morpholinopyridin-4-yl)-4-methvlphenyl)-2 (trifluoromethyl)isonicotinamide as Raf inhibitors for the treatment of cancer

CRYSTALLINE FORMS OF SOMATOSTATIN MODULATORS

MANUFACTURING METHODS AND POLYMORPHS OF A THIAZOLINE ANTI-HYPERALGESIC AGENT

Pharmaceutical composition comprising 5-methoxy-N,N-dimethyltryptamine

Pharmaceutically acceptable salts of [2-(3-fluoro-5-methane-sulfonylphenoxy)ethyl](propyl)amine and uses thereof

Crystalline 5-(dimethylamino)-N-(4-(morpholinomethyl) phenyl)naphthalene-1-sulfonamide di-hydrochloride di-hydrate

Solids of MEK inhibitor N-((R)-2,3-dihydroxypropoxy)-3,4-difluoro-2-(2-fluoro-4-iodophenylamino)-benzamide and uses thereof

Composition of BHET and use thereof

PHARMACEUTICAL COMPOSITION COMPRISING A TETRAHYDROPYRAZOLOPYRIMIDINONE COMPOUND

Polymorphic forms of (R)-2-hydroxy-2-methyl-4-(2,4,5-trimethyl-3,6-dioxocyclohexa-1,4-dienyl)butanamide

Processes for the preparation of (R)-2-(7-(4-cyclopentyl-3-(trifluoromethyl)benzyloxy)-1,2,3,4-tetrahydrocyclopenta[b]indol-3-yl)acetic acid and salts thereof

LIGAND-EXCHANGEABLE JANUS NANOPARTICLES AND METHODS OF MAKING THE SAME

SORCS2 CRYSTAL STRUCTURE AND USES THEREOF

Crystalline form of vascular leakage blocker compound

PROCESS FOR THE PREPARATION OF ABROCITINIB

A PROCESS FOR THE PREPARATION OF VENETOCLAX AND ITS POLYMORPHS THEREOF

CRYSTALLINE FORMS OF A CYCLIN-DEPENDENT KINASE INHIBITOR

NOVEL CRYSTALLINE HYDRATE OF TOPRAMEZONE SODIUM SALT AND PREPARATION METHOD THEREFOR

COCRYSTALS OF POSACONAZOLE, METHODS OF MAKING AND USING SAME

Crystal form of 6-(cyclopropanecarboxamido)-4-((2-methoxy-3-(1-methyl-1H-1,2,4-triazol-3-yl)phenyl)amino)-N-(methyl-d) pyridazine-3-carboxamide

Crystalline forms of a somatostatin modulator

SOLID STATE FORMS OF TAFAMIDIS AND SALTS THEREOF

Solid forms of an N-terminal domain androgen receptor inhibitor and uses thereof

Crystalline form of compound, method for preparing the same, pharmaceutical composition and use

Composition comprising a benzoate salt of 5-methoxy-N,N-dimethyltryptamine

Methods of treating neurofibromatosis with N-((R)-2,3-dihydroxypropoxy)-3,4-difluoro-2-(2-fluoro-4-iodophenylamino)-benzamide

Crystal form and amorphous form of dezocine analogue hydrochloride

Nitrile-containing antiviral compounds

CRYO-CRYSTALLISED FAT

NOVEL CRYSTALLINE FORM OF PYROXASULFONE, METHODS FOR ITS PREPARATION AND USE OF THE SAME

PROCESS FOR THE PREPARATION OF AMORPHOUS MIDOSTAURIN WITH A LOW CONTENT OF RESIDUAL ORGANIC SOLVENT

Process for preparing substituted polycyclic pyridone derivative and crystal thereof

Processes for the preparation of (3S,4R)-3-ethyl-4-(3H-imidazo[1,2-a]pyrrolo[2,3-e]-pyrazin-8-yl)-n-(2,2,2-trifluoroethyl)pyrrolidine-1-carboxamide and solid state forms thereof

POTASSIUM SALT CRYSTAL FORM B OF PHOSPHODIESTERASE TYPE 5 INHIBITOR, AND PREPARATION METHOD AND USE THEREFOR

Substituted imidazo[2,1-f][1,2,4]triazines as PI3K-gamma inhibitors

Continuous Process for the Preparation of Anticholinergic Drugs

CRYSTALLINE FORMS OF 7-CHLORO-2-(4-(3-METHOXYAZETIDIN-1-YL)CYCLOHEXYL)-2,4-DIMETHYL-N-((6-METHYL-4-(METHYLTHIO)-2-OXO-1,2-DIHYDROPYRIDIN-3-YL)METHYL)BENZO[D][1,3]DIOXOLE-5-CARBOXAMIDE

Solid forms of an HIV capsid inhibitor

COMPOUND FOR ORGANIC ELECTRIC DEVICE, ORGANIC ELECTRIC DEVICE USING THE SAME, AND ELECTRONIC DEVICE THEREOF

IMPROVED PROCESS FOR THE PREPARATION OF 2-(3,5-DICHLOROPHENYL)-1,3-BENZOXAZOLE-6-CARBOXYLIC ACID OR ITS PHARMACEUTICALLY ACCEPTABLE SALTS AND POLYMORPHS THEREOF

CRYSTAL FORM OF HYPOXIA-INDUCIBLE FACTOR-PROLYL HYDROXYLASE INHIBITOR

Preparation Method for Metformin Hydrochloride

Crystalline Form of y-Aminobutyric Acid Analog

CRYSTAL FORM I OF CURCUMIN DERIVATIVE, PREPARATION METHOD THEREFOR AND APPLICATION THEREOF

Continuous crystallization of cannabinoids in a stirred-tank reactor

THERMOPLASTIC RESIN, METHOD FOR MANUFACTURING SAME, AND OPTICAL LENS

CONTINUOUS PROCESS FOR PREPARING THE CRYSTALLINE FORM II OF SOTAGLIFLOZIN

Method for synthesizing furoimidazopyridine compound, polymorphic substance and polymorphic substance of salt

Polymorph of latrepirdine dihydrochloride

CRYSTAL FORM AND SALT OF QUINAZOLINE COMPOUND AND PREPARATION METHOD THEREOF

Crystalline (2S,4R)-5-(5′-chloro-2′-fluoro-[1,1′-biphenyl]-4-yl)-2-(ethoxymethyl)-4-(3-hydroxyisoxazole-5-carboxamido)-2- methylpentanoic acid and uses thereof

PROCESS FOR PREPARING XPO1 INHIBITORS AND INTERMEDIATES FOR USE IN THE PREPARATION OF XPO1 INHIBITORS

PROCESS FOR PREPARATION OF ENZALUTAMIDE

Methods for making and using endoxifen

CRYSTAL FORM OF TREPROSTINIL SODIUM SALT AND PREPARATION METHOD THEREFOR

CRYSTALLINE CANNABIGEROL

FORMULATIONS OF T-TYPE CALCIUM CHANNEL MODULATORS AND METHODS OF USE THEREOF

De novo design of potent and selective interleukin mimetics

PROCESS FOR PREPARING THE CRYSTALLINE FORM II OF SOTAGLIFLOZIN

Crystalline forms of Tenofovir alafenamide

MORPHIC FORMS OF MARIZOMIB AND USES THEREOF

Solid state forms

CRYSTALLINE SALT FORMS OF 6-(CYCLOPROPANECARBOXAMIDO)-4-((2-METHOXY-3-(1-METHYL-1H-1,2,4-TRIAZOL-3-YL)PHENYL)AMINO)-N-(METHYLD3) PYRIDAZINE-3-CARBOXAMIDE

Crystalline forms of a MAGL inhibitor

SELECTIVE HISTAMINE H3 ANTAGONIST ACID ADDITION SALTS AND PROCESS FOR THE PREPARATION THEREOF

CRYSTAL FORM OF C-MET/AXL INHIBITOR

PROCESS FOR THE PREPARATION OF HIGHLY PURE ERLOTINIB HYDROCHLORIDE

Method for Producing (3S)-3-(4-chloro-3-{[(2S,3R)-2-(4-chlorophenyl)-4,4,4-trifluoro-3-methylbutanoyl]amino}phenyl)-3-cyclo-propylpropanoic Acid and the Crystalline Form Thereof for Use as a Pharmaceutical Ingredient

SOLID STATE FORMS OF RELUGOLIX

Synthesis method of furoimidazopyridine compound, crystal form of furoimidazopyridine compound, and crystal form of salt thereof

Salts of TAM inhibitors

CRYSTALLINE FORM OF TELMAPITANT OR (5R,8S)-8-[[(1R)-1-[3,5-BIS(TRIFLUOROMETHYL)PHENYL]ETHOXY]METHYL]-8-PHENYL-1,3,7-TRIAZASPIRO[4.5]DECANE-2,4-DIONE

Methods of preparing heteroaryl-ketone fused azadecalin glucocorticoid receptor modulators

Cholinesterase inhibitor polymorph and application thereof

Heterocyclic compounds, preparation methods and uses thereof

SOLID STATE FORMS OF SAGE-217 AND PROCESSES FOR PREPARATION THEREOF

MORPHIC FORMS OF 4-AMINO-7-(3,4-DIHYDROXY-5-(HYDROXYMETHYL)TETRAHYDROFURAN-2-YL)-2-METHYL-7H-PYRROLO[2,3-d]PYRIMIDINE-5-CARBOXAMIDE AND USES THEREOF

AMORPHOUS AND CRYSTALLINE FORMS OF RELUGOLIX

Solid forms of Alpha-1062 gluconate

Crystal form of Wee1 inhibitor compound and use thereof

3-(ethoxydifluoromethyl)-6-(5-fluoro-6-(2,2,2-trifluoroethoxy)pyridin-3-yl)-[1,2,4]triazolo[4,3-a]pyridine as an ion channel modulator

CRYSTAL FORMS OF ACRYLIC ACID DERIVATIVES, PREPARATION METHOD THEREFOR AND USE THEREOF

Crystal form of pyrimidine sulfonamide compound and preparation method therefor

CRYSTALLINE FORMS OF N-(4-(4-(CYCLOPROPYLMETHYL)PIPERAZINE-1-CARBONYL)PHENYL)QUINOLINE-8-SULFONAMIDE

SOLID FORM OF AROMATIC COMPOUND AND PREPARATION METHOD THEREFOR

Solid forms of n-tert-butyl-4[[2-(5-chloro-2-hydroxy-phenyl)acetyl]amino]pyridine-2-carboxamide

PROCESS FOR CRYSTALLIZATION OF HIGH PURITY LUTEIN ESTERS FROM MARIGOLD EXTRACTS

2,3,5-trimethyl-6-nonylcyclohexa-2,5-diene-1,4-dione for suppressing and treating alpha-synucleinopathies, tauopathies, and other disorders

Inhalable imatinib formulations, manufacture, and uses thereof

Tertiary alcohols as PI3K-γ inhibitors

Compound containing fused ring, use thereof and pharmaceutical composition containing same

3-ARYLOXY-3-FIVE-MEMBERED HETEROARYL PROPYLAMINE COMPOUND, AND CRYSTAL FORM AND USE THEREOF

SALTS OF A CLASS OF PYRIMIDINE COMPOUNDS, POLYMORPHS, AND PHARMACEUTICAL COMPOSITIONS THEREOF, PREAPRATION METHODS THEREFOR AND USES THEREOF

Crystal Form of Quinazolinone Compound and Preparation Method Therefor

PROCESSES FOR PREPARING 2-(4-CHLOROPHENYL)-N-((2-(2,6-DIOXOPIPERIDIN-3-YL)-1-OXOISOINDOLIN-5-YL)METHYL)-2,2-DIFLUOROACETAMIDE

NOVEL CRYSTAL FORM OF 3-(4-(BENZYLOXY)PHENYL)HEX-4-INOIC ACID DERIVATIVE

CRYSTALLINE POLYMORPHS OF 1,6-DIBROMO-1,6-DIDEOXY-DULCITOL

Crystals

Hydroxypyridoxazepines as NRF2 activators

Crystal form of upadacitinib, preparation method therefor, and use thereof

POLYMORPHS OF 7-CYCLOPENTYL-N,N-DIMETHYL-2-{[5-(PIPERAZIN-1-YL) PYRIDIN-2-YL]-AMINO}-7H-PYRROLO[2,3-D]PYRIMIDINE-6-CARBOXAMIDE AND ITS PHARMACEUTICALLY ACCEPTABLE SALTS AND PROCESS FOR THE PREPARATION THEREOF

Crystalline salts of a B-RAF kinase inhibitor

CRYSTAL POLYMORPHISM OF PI3K INHIBITOR AND METHOD FOR PREPARING SAME

CRYSTAL FORM S4 OF THE PLK4 INHIBITOR (1R,2S)-(E)-2-(3-(4-((CIS-2,6-DIMETHYLMORPHOLINO)METHYL)STYRYL)- 1 H-IMIDAZOL-6- YL)-5'-METHOXYSPIRO[CYCLOPROPANE-1,3'-INDOLIN]-2'-ONE FUMARATE

CRYSTALLINE FORM OF A BET-INHIBITOR AND MANUFACTURE THEREOF

Crystalline forms of imidacloprid and methods of use thereof

SOLID FORM OF DIAMINOPYRIMIDINE COMPOUND OR HYDRATE THEREOF, PREPARATION METHOD THEREFOR, AND APPLICATION THEREOF

Crystalline salts of a plasma kallikrein inhibitor

Crystalline forms and methods of producing crystalline forms of a compound

Metastable crystal modification and method for producing the same (I)

Honokiol crystal forms, amorphous form and preparation thereof

METHOD FOR PREPARING CANNABIDIOL COMPOUND

Salts of selective estrogen receptor degraders

Method for resolving optical isomer by using supercritical fluid extraction technology

SOLID FORMS OF AN ORALLY-DELIVERED BETA-LACTAMASE INHIBITOR AND USES THEREOF

CRYSTAL FORM OF EGFR INHIBITOR AND PREPARATION METHOD THEREOF

FGFR inhibitors and methods of making and using the same

CRYSTALLINE FORMS OF N-(5-(5-((1R,2S)-2-FLUOROCYCLOPROPYL)-1,2,4-OXADIAZOL-3-YL)-2-METHYLPHENYL)IMIDAZO[1,2-A]PYRIDINE-3-CARBOXAMIDE

CRYSTAL FORM OF PHOSPHODIESTERASE INHIBITOR,PREPARATION METHOD THEREFOR AND USE THEREOF

CYCLOPENTANE COMPOUNDS

CO-CRYSTALLINE EFINACONAZOLE, AND METHOD FOR PRODUCING SAME

Highly purified batches of pharmaceutical grade 1-deoxygalactonojirimycin compounds

Method of preparing a DON prodrug from L-pyroglutamic acid

Formulations of pimavanserin

SALT FORM AND CRYSTAL FORM OF A2A RECEPTOR ANTAGONIST AND PREPARATION METHOD THEREFOR

BRD4 INHIBITOR COMPOUND IN SOLID FORM AND PREPARATION METHOD THEREFOR AND USE THEREOF

Pyrrolopyrazole derivative

Crystalline berberine ascorbate salt, methods of preparation and applications thereof

POLYMORPHS OF A CARDIAC TROPONIN ACTIVATOR

Polymorphs and cocrystals of a cardiac troponin activator

BULLEYACONITINE D CRYSTAL AND PREPARATION METHOD THEREFOR AND APPLICATION THEREOF

PIROCTONE OLAMINE RECRYSTALLIZATION

Highly purified batches of pharmaceutical grade migalastat and methods of producing the same

NOVEL TERNARY MOLECULAR COMPLEX OF TAMIBAROTENE FOR CANCER STEM CELLS TREATMENT

NEBULIZED IMATINIB FORMULATIONS, MANUFACTURE, AND USES THEREOF

(AZA)Benzothiazolyl Substituted Pyrazole Compounds

Solid form of (-)-Ambrox formed by a bioconversion of homofarnesol in the presence of a biocatalyst

Selective and noncovalent inhibitors of oncogenic RAS mutants

Methods for producing crystalline L-glufosinate ammonium monohydrate

Crystalline form of L-glufosinate ammonium salt and process for production thereof

Crystal form of acid addition salt of furopyrimidine compound

Crystal Forms of (S)-4-(8-amino-3-(1-(but-2-ynoyl)-pyrrolidin-2-yl)imidazo[1,5-a]pyrazin-1-yl)-n-(pyridin-2-yl)benzamide

FGFR INHIBITOR COMPOUND IN SOLID FORM AND PREPARATION METHOD THEREFOR

Purinone derivative hydrochloride

Solid forms of emetine

Integrin inhibitor and uses thereof

Pharmaceutical salts of benzothiazol compounds, polymorphs and methods for preparation thereof

CRYSTAL FORMS OF A PYRIDAZINONE TRPC INHIBITOR

CRYSTALLIZATION OF SMAC MIMIC USED AS IAP INHIBITOR AND PREPARATION METHOD THEREOF